BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 4121601)

  • 1. The halo naevus and malignant melanoma.
    Lancet; 1973 May; 1(7810):982. PubMed ID: 4121601
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological associations of the halo naevus with cutaneous malignant melanoma.
    Copeman PW; Lewis MG; Phillips TM; Elliott PG
    Br J Dermatol; 1973 Feb; 88(2):127-37. PubMed ID: 4574770
    [No Abstract]   [Full Text] [Related]  

  • 3. Melanocyte mutation in halo naevus and malignant melanoma?
    Bennett C; Copeman PW
    Br J Dermatol; 1979 Apr; 100(4):423-6. PubMed ID: 378250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma cytoplasmic humoral antibody test. A diagnostic adjunct.
    Copeman PW; Elliott PG
    Br J Dermatol; 1976 May; 94(5):565-8. PubMed ID: 773408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halo nevus: competent surveillance of potential melanoma?
    Krebs JA; Roenigk HH; Deodhar SD; Barna B
    Cleve Clin Q; 1976; 43(1):11-5. PubMed ID: 1261030
    [No Abstract]   [Full Text] [Related]  

  • 6. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.
    Hellström I; Warner GA; Hellström KE; Sjögren HO
    Int J Cancer; 1973 Mar; 11(2):280-92. PubMed ID: 4790696
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: The halo naevus and cutaneous malignant melanoma.
    Whimster IW
    Br J Dermatol; 1974 Jan; 90(1):111-3. PubMed ID: 4811833
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of cell-mediated immunity to melanoma cells in patients with vitiligo, halo nevi or melanoma.
    Mitchell MS; Nordlund JJ; Lerner AB
    J Invest Dermatol; 1980 Aug; 75(2):144-7. PubMed ID: 7410884
    [No Abstract]   [Full Text] [Related]  

  • 9. Melanoma specific protein: occurrence in the urine of patients with halo naevus and vitiligo.
    Cooke KB; Bennett C; Staughton RC
    Br J Dermatol; 1978 Jun; 98(6):663-8. PubMed ID: 678452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halo naevus--a frustrated malignant maelanoma.
    Lewis MG; Copeman PW
    Br Med J; 1972 Apr; 2(5804):47-8. PubMed ID: 4552592
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitiligo and malignant melanoma: a significant association?
    Gregor RT
    S Afr Med J; 1976 Aug; 50(3F):1447-9. PubMed ID: 973163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigens associated with tumor progression in melanocytic neoplasia.
    Elder DE; Herlyn M
    Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Delayed hypersensitivity reaction in malignant melanoma].
    Gorodilova VV; Saraeva ZM; Slesareva RI; Monzul' GD
    Vopr Onkol; 1973; 19(3):23-7. PubMed ID: 4762691
    [No Abstract]   [Full Text] [Related]  

  • 14. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
    Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
    Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
    [No Abstract]   [Full Text] [Related]  

  • 15. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
    Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
    G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cockade nevus. Unusual variation of nevus cell nevus].
    Happle R
    Hautarzt; 1974 Dec; 25(12):594-6. PubMed ID: 4615078
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic reaction-readiness in malignant melanoma].
    Bickhardt R; Kunze J
    Z Hautkr; 1974 Apr; 49(8):315-33. PubMed ID: 4599330
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificity of tumor-associated antibodies in sera of patients with uveal melanoma.
    Brownstein S; Phillips TM; Lewis MG
    Can J Ophthalmol; 1978 Jul; 13(3):190-3. PubMed ID: 698890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of two distinct tumor-associated antibodies in the serum of melanoma patients.
    Lewis MG; Phillips TM
    J Natl Cancer Inst; 1972 Sep; 49(3):915-7. PubMed ID: 4630549
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrosis in regressing melanoma versus nonfibrosis in halo nevus upon melanocyte disappearance: could it be related to a different cytokine microenvironment?
    Moretti S; Spallanzani A; Pinzi C; Prignano F; Fabbri P
    J Cutan Pathol; 2007 Apr; 34(4):301-8. PubMed ID: 17381800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.